IMVT vs INSM Stock Comparison

INSM currently leads IMVT in this stock comparison, with AIQ scores of 57 vs 52. The clearest difference is quality.

Market data as of Nov 15, 2026 market close· AIQ score gap 5 points
IMVT
Healthcare
vs
INSM
Healthcare
IMVT
Immunovant, Inc.
Price
$34.18
Day move
-2.48%
AIQ Score
52/100
Best edge
Balanced
Sector
Healthcare
INSM
Insmed Incorporated
Leads
Price
$121
Day move
+2.62%
AIQ Score
57/100
Best edge
Quality
Sector
Healthcare

What is the main difference between IMVT and INSM?

INSM leads the current stock comparison as Insmed Incorporated, with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Immunovant, Inc. vs Insmed Incorporated

Data as of Nov 15, 2026· market close· Healthcare· Coverage 60/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

INSM leads

INSM leads by 5 AIQ points, primarily on Quality, having only recently taken the lead back from IMVT.

Fragile: 2 of 4 evidence groups support INSM, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 2 of 4Comparison trend: Reversed
IMVT

Immunovant, Inc.

AIQ Score
52/100
AIQ Edge Score
9/10
INSM

Insmed Incorporated

Leads
AIQ Score
57/100
AIQ Edge Score
6/10

The Algovestiq AIQ Score currently favors INSM over IMVT, 57 versus 52 as of Nov 15, 2026. INSM's advantage is driven primarily by stronger quality. INSM also shows the stronger technical structure relative to its 50-day moving average. 2 of 4 covered evidence groups favor INSM today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 5 points. INSM lead: Reversed — IMVT led by 3 AIQ points 30 sessions ago; INSM now leads by 5.

Compare Immunovant, Inc. and Insmed Incorporated across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

IMVT
+332.1%
INSM
+299.2%

Price return comparison

Growth of $10,000, price only

IMVT $43,211 · INSM $39,921

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare IMVT and INSM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

IMVT advantage
0
INSM advantage
  • Quality42 vs 58
    INSM +16
  • Risk Resilience52 vs 49
    Even
  • Momentum61 vs 61
    Even

2 of 4 evidence groups favor INSM. INSM’s edge is concentrated in quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

IMVT+1 AIQ

Largest factor move: Momentum +3

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
INSM+1 AIQ

Largest factor move: Momentum +3

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon

INSM's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — IMVT and INSM both carry a full feed there.

The central trade-off

INSM (Insmed Incorporated): the stronger current systematic profile, led by quality.

IMVT (Immunovant, Inc.): the counter-case, on technicals — but at materially higher volatility, 72.6% against 65.3%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

INSM

INSM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

INSM

INSM on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

Even

The two are level on Momentum.

Lower downside

INSM

INSM carries the lower 1-month annualized volatility.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureIMVTINSMNote
Implied upside to target—+57.7%Level
Target dispersion—+30.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1724Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 4 covered evidence groups favor INSM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreINSM52 vs 57
FundamentalsINSMon balancerevenue growth -100% vs 23.3%; EPS growth 37.3% vs -6.7%; TTM ROE -14.8% vs -13.8%; gross margin 100% vs 84.3%; operating margin -74.9% vs -35.6% — INSM takes 3 of 5 decided legs, not all of them
ValuationNot coveredNot covered
TechnicalsIMVTPrice vs 50-day 4.7% vs 9.3%; vs 200-day 5.7% vs -1.6%
Risk ResilienceEvenRisk Resilience 52 vs 49
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of IMVT and INSM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 5 points. (argues the conclusion is provisional)
  • Only 2 of 4 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on INSM.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

INSM lead: Reversed — IMVT led by 3 AIQ points 30 sessions ago; INSM now leads by 5.

May 27IMVT leads above the line · INSM leads belowNov 13
Today
INSM +5
52 vs 57
7 sessions ago
INSM +7
49 vs 56
30 sessions ago
IMVT +3
49 vs 46
90 sessions ago
IMVT +15
66 vs 51

The lead changed hands 2 times in this window, most recently on Nov 5 when INSM moved ahead of IMVT.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

IMVTConflicted

4 bullish / 3 bearish / 1 neutral, conflicted

Only IMVT

  • Golden Cross Active — bullish, trend, long horizon (0.90%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • RSI Bearish Divergence — bearish, momentum, medium horizon
  • Uptrend Structure Active — bullish, trend, long horizon
INSMConflicted

2 bullish / 2 bearish / 2 neutral, conflicted

Only INSM

  • Death Cross Active — bearish, trend, long horizon (11.14%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon

Both carry 3 more signals that do not separate them: ATR Expansion - Breakout Mode, Keltner Channel Breakout, Low Volume Rally Warning.

INSM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

IMVTDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.48%, AIQ +1 points).

INSMConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +2.62%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1IMVT closes the Quality gap — currently 16 points behind, the largest single contributor to INSM's edge.
  2. 2IMVT's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3INSM's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

INSM leads on balance
MetricIMVTINSM
Revenue growth (YoY)-100%23.3%
EPS growth (YoY)37.3%-6.7%
Gross margin100%84.3%
Operating margin-74.9%-35.6%
Return on equity (TTM)-14.8%-13.8%
Debt to equity01.02

Performance

IMVT leads 5 of 6 windows
MetricIMVTINSM
1 week (5 sessions)12%5.9%
1 month (20 sessions)27.9%25.9%
3 months (63 sessions)-21.8%-5.6%
6 months (126 sessions)24.3%11%
Year to date34.5%-30.4%
1 year (252 sessions)45.8%-37.7%

Technicals

IMVT has the stronger structure
MetricIMVTINSM
RSI (14)58.165
ADX (14)33.130.8
Price vs 50-day4.7%9.3%
Price vs 200-day5.7%-1.6%
Volatility (1M, annualized)72.6%65.3%

Risk

Split
MetricIMVTINSM
Beta1.580.55
Sharpe ratio0.9-0.48
Sortino ratio1.77-0.72
Max drawdown-40.5%-56.5%
Current drawdown-24%-42.7%
Annualized volatility58.6%63.1%
Value at risk (95%)-4.9%-4.5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, IMVT or INSM?

On the Algovestiq AIQ Score, INSM is the stronger of the two as of Nov 15, 2026, scoring 57 against IMVT's 52. The edge comes from quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is IMVT or INSM the better buy right now?

INSM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 5 points. Treat the lead as provisional.

Why does the AIQ Score favor INSM over IMVT?

The composite weights Quality, Value, Momentum and Risk Resilience. INSM leads Quality by 16 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, IMVT or INSM?

Analyst price targets imply not covered upside for IMVT and +57.7% for INSM. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, IMVT or INSM?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, IMVT or INSM?

INSM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, IMVT or INSM?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, IMVT or INSM?

INSM is the more resilient of the two, so the other name carries the higher downside risk. INSM carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is IMVT more profitable than INSM?

The profitability evidence is mixed: gross margin 100% vs 84.3%; operating margin -74.9% vs -35.6%; ttm roe -14.8% vs -13.8%. IMVT leads on one measure and INSM on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is INSM's lead over IMVT getting stronger or weaker?

INSM lead: Reversed — IMVT led by 3 AIQ points 30 sessions ago; INSM now leads by 5. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-11-05, when INSM moved ahead of IMVT.

What would change the IMVT vs INSM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: IMVT closes the Quality gap — currently 16 points behind, the largest single contributor to INSM's edge; IMVT's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; INSM's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about IMVT and INSM?

IMVT: 4 bullish / 3 bearish / 1 neutral, conflicted. INSM: 2 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on IMVT is Golden Cross Active (bullish, long horizon). On INSM it is Death Cross Active (bearish, long horizon).

Compare IMVT and INSM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.